Influence
June 8, 2020

Conference sparks discussion about monitoring impact of healthcare AI

A Regenstrief Institute and Indiana Clinical and Translational Sciences Institute (CTSI) conference on the use of artificial intelligence (AI) in healthcare created a discussion about monitoring the impact of algorithms on care.

During the second day of the conference, Regenstrief President and Chief Executive Officer Peter Embí, M.D., M.S., made a case for “algorithmovigilance,” which is the systematic monitoring of healthcare algorithms to develop and respond to expected and unexpected effects. He stated he believes this surveillance is necessary to address and correct data biases as well as better understand the generalizability of algorithms.

The panel discussion was the subject of a Healthcare Innovation article.

Read the article

In addition to monitoring the impact of AI, the three-day conference, Artificial Intelligence: Applying Research and Engineering Solutions for Emergent Needs in Healthcare, covered the application of AI in healthcare settings, the necessary building blocks to create effective AI and the future applications of this technology.

More than 500 people from 16 countries signed up to attend.

Related News

Office of Strategic Innovation helps connect startups with research expertise

Moving healthcare innovations from promising ideas to real-world impact requires collaboration between researchers, entrepreneurs, healthcare organizations and industry partners.

Pilot awards to advance nursing home clinical trials nationwide

Pilot awards to advance nursing home clinical trials nationwide

The National Institutes of Health’s (NIH) National Institute on Aging (NIA) awarded two pilot projects funded through NEXT STEPs

Regenstrief researcher Jiang Bian named Fellow of ACTS inaugural cohort

Jiang Bian, PhD, of the Regenstrief Institute has been named a 2026 Fellow of the Association for Clinical and Translational Science (ACTS),